美国 · 股市与财经 · Washington Post Business
Health Brief: Eli Lilly takes on retatrutide copycats
Eli Lilly is suing five more companies accused of selling illicit copies of its experimental weight loss drug retatrutide as CEO Dave Ricks presses regulators to do more Insurers…
在 Washington Post Business 阅读全文 登录后可收藏MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.washingtonpost.com)
